Log in or Sign up for Free to view tailored content for your specialty!
Osteoarthritis and Bone Disorders News
Risk stratification tool predicts functional disability in patients at high risk for OA
Easily acquired data — such as education, depression symptoms, strenuous activity and obesity — can help identify functional decline risk among individuals before they develop osteoarthritis, according to a study published in the Annals of the Rheumatic Diseases.
Vitamin D supplements linked to less cartilage, joint loss in knee OA
Among patients with knee osteoarthritis, higher intake with both vitamins C and D is associated with less cartilage degeneration, while supplementation with vitamin D alone over 4 years is linked with significantly less progression of knee joint abnormalities, according to data published in Arthritis Care & Research.
Log in or Sign up for Free to view tailored content for your specialty!
Personalized Stem Cells Inc gets new drug application clearance to use stem cells for knee OA
Personalized Stem Cells Inc. announced it has received FDA approval for an investigational new drug application for the use of adipose-derived stem cells for the treatment of osteoarthritis.
Socioeconomic factors may moderate racial disparities in OA function
Although black adults with knee osteoarthritis demonstrate worse performance-based physical function than white patients, these disparities are diminished when adjusting for socioeconomic and physical health factors, according to findings published in Arthritis Care & Research.
1 in 4 early-middle-aged adults has osteopenia
More than 25% of early-middle-aged adults had osteopenia in their neck, according to findings recently published in the Journal of the American Osteopathic Association.
Greater hip BMD gains seen with denosumab vs. teriparatide after long-term bisphosphonate use
Long-term bisphosphonate users who switched to the human monoclonal antibody denosumab experienced a gain in hip bone mineral density in the first year of therapy, whereas patients who switched to teriparatide experienced a transient loss in hip BMD, suggesting clinicians should exercise caution when changing osteoporosis agents for patients at high risk for hip fracture, according to a real-world analysis of electronic medical records.
Fasinumab improves pain, function in OA
Fasinumab, a recombinant, fully-human anti-nerve-growth-factor antibody, improved pain and physical function in patients with osteoarthritis, at various dose levels, even among individuals who experienced little benefit from previous analgesic therapy, according to recent findings in Arthritis & Rheumatology.
Osteoarthritis more than doubles risk for multiple comorbidities
Individuals with osteoarthritis have a 2.5-times greater risk for having three or more other chronic conditions, including stroke and peptic ulcers, compared with those without osteoarthritis, according to findings published in Arthritis Care & Research.
Physiotherapists only moderately confident in assessing fall risk in OA
Physiotherapists reported only moderate confidence in assessing fall risk and providing fall-prevention care for patients with osteoarthritis, and although asking such patients about their history of falls is common, physiotherapists rarely use screening tools or specific balance tests, according to survey results published in Arthritis Care & Research.
Metformin reduces risk of knee OA progression in patients with obesity
Metformin use was linked to a reduced rate of medial cartilage loss that may, in turn, reduce the risk for total knee replacement among patients with osteoarthritis who are obese, according to data published in Arthritis Research & Therapy.